Main Library
HHS aims to use value-based care payment models to lower drug prices

HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Robert KingNo CommentsFierce HealthcarePharmacy Services

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices.

The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms such as giving Medicare price negotiation authority and cap Part D catastrophic spending.

“By promoting negotiation, competition, and innovation in the health care industry, we will ensure cost fairness and protect access to care,” HHS Secretary Xavier Becerra said in a statement Thursday.

Full Article

: CMMI, drug prices, HHS, Pharmaceuticals

Related Posts

Over 50 Lawmakers Urge Administration to End Direct Contracting

January 17, 2022aco

ACOs Angling for a Bigger Role in Health Equity

October 4, 2021Garrett Schmitt

A Roadmap for Value-Based Payment in 2030

March 13, 2021Garrett Schmitt

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • RECORDED WEBINAR: How to Prepare for Market Changes to Health Equity and Social Determinants of Health
  • RECORDED WEBINAR: How Innovative Digital Trends are Revolutionizing ACO Outcomes
  • RECORDED WEBINAR: Unlocking the power of digital health: How ACOs can deliver value through digital platforms
  • The Return to Normal: Medicaid Redetermination Edition
  • RECORDED WEBINAR: Transforming Transitions for High-Risk Patients: How an IPA revamped care transitions to improve outcomes for their high-risk patients
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us